ORTHOFIX Inc

Website Links

Description

Clinical research is vital to sustain our commitment to innovation and the continuous improvement of our products at Orthofix. The Clinical Affairs Department is conducting numerous studies both domestically and internationally. In collaboration with approximately 81 study sites, we have more than 1,200 patients participating in clinical studies that will assist with ensuring that we are delivering quality products that exceed customer expectations.

Our successes stem from a relentless desire to ensure that we are meeting the needs of our customers.

Mr. Heggestad has more than 20 years of experience in financial leadership roles in the medical device industry. He previously served as Executive Vice President and CFO at American Medical Systems Holdings, Inc. where his supervisory responsibilities included Finance & Accounting, Investor Relations, Internal Auditing, IT, Business Development and Strategic Planning among others.

Mr. Mason became the President and Chief Executive Officer of Orthofix in 2013. He had previously served Orthofix from 2003 to 2010 in roles of increasing responsibility, including Group President of North America. Mr. Mason joined the Company upon the acquisition of Breg, Inc., which he founded in 1989 and built through rapid product innovation and by maximizing distribution capabilities.

Orthofix International N.V. is a diversified, global medical device company focused on improving patients' lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide. Headquartered in Lewisville, TX , the Company has four strategic business units that include BioStim, Biologics, Extremity Fixation and Spine Fixation. Orthofix products are widely distributed via the Company's sales representatives, distributors and its subsidiaries.

Fact sheet

Company contacts

Products & services

Similar companies nearby